Showing results (471-480 of 576) with videos related to
Sort By:
Pageof 58
Antimicrobial Agents and Chemotherapy|July 18, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic modelZakuan Z Deris, Heidi H Yu, Kathryn Davis, et al.Journal of Clinical Gastroenterology|March 15, 2016
Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 StudiesLuis Furuya-Kanamori, Suhail A R Doi, David L Paterson, et al.The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2022
Clinical Implementation of Routine Whole-genome Sequencing for Hospital Infection Control of Multi-drug Resistant PathogensBrian M Forde, Haakon Bergh, Thom Cuddihy, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeDavid van Duin, Judith J Lok, Michelle Earley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2012
Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United StatesYohei Doi, Yoon Soo Park, Jesabel I Rivera, et al.Trials|January 28, 2015
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trialPatrick N A Harris, Anton Y Peleg, Jon Iredell, et al.Journal of Clinical Microbiology|January 9, 2015
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producersHosam M Zowawi, Anna L Sartor, Hanna E Sidjabat, et al.The Journal of Antimicrobial Chemotherapy|November 2, 2017
Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coliMinh-Duy Phan, Nguyen Thi Khanh Nhu, Maud E S Achard, et al.International Journal of Antimicrobial Agents|June 24, 2020
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.Pageof 58